These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24914510)

  • 21. Stress Ulcer Prophylaxis.
    Barletta JF; Bruno JJ; Buckley MS; Cook DJ
    Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
    Avendaño-Reyes JM; Jaramillo-Ramírez H
    Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How important are proton pump inhibitors in the prevention of stress ulcers and stress-associated gastrointestinal bleeding in ICU patients?].
    Kasper P; Janssens U; Michels G
    Med Klin Intensivmed Notfmed; 2019 May; 114(4):350-354. PubMed ID: 30506170
    [No Abstract]   [Full Text] [Related]  

  • 24. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The new algorithm of diagnostics, prevention and treatment of acute erosive and ulcerative lesions of the gastrointestinal tract].
    Dzhitava IG; Smirnova GO; Martirosov AV
    Eksp Klin Gastroenterol; 2011; (5):63-8. PubMed ID: 21916237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
    Yang Z; Wu Q; Liu Z; Wu K; Fan D
    Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
    Kawai T; Yagi K; Moriyasu F
    Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
    Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
    J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress ulcer prophylaxis in the ICU: who, when, and how?
    Bardou M; Barkun AN
    Crit Care Med; 2013 Mar; 41(3):906-7. PubMed ID: 23425820
    [No Abstract]   [Full Text] [Related]  

  • 32. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
    Zhang YS; Li Q; He BS; Liu R; Li ZJ
    World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
    Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
    Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of gastric prophylaxis against stress bleeding reflects inadequate pH control.
    Mesquita WJ; Kline CM; Vernier P; Ledgerwood AM; Lucas CE
    Surgery; 2018 Oct; 164(4):733-737. PubMed ID: 30041965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Famotidine versus pantoprazole.
    Lwin AA
    Am J Crit Care; 2008 Jul; 17(4):311-2; author reply 312. PubMed ID: 18593828
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
    Huggins RM; Scates AC; Latour JK
    Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding in the upper part of the gastrointestinal tract due to stress ulcers.
    Carlson RW; Baker L; Andhavarapu S
    Am J Crit Care; 2008 Mar; 17(2):148-9. PubMed ID: 18310652
    [No Abstract]   [Full Text] [Related]  

  • 40. Upper gastrointestinal bleeding in critically ill patients: proton-pump inhibitors, histamine-2 receptor antagonists or placebo? Many questions remain unanswered.
    García-Rayado G; Lanas A
    Curr Med Res Opin; 2018 Nov; 34(11):1881-1883. PubMed ID: 30095019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.